The financial world is watching intently as Warren Buffett's Berkshire Hathaway has accumulated unprecedented cash reserves. By the third quarter of 2024, the conglomerate's liquid assets surged to $325.2 billion, a substantial jump from $276.9 billion just one quarter prior. This dramatic buildup r

When inflation bites and recession whispers loom, many Americans face the same temptation: pause those 401(k) contributions and pocket the cash. It sounds logical—boost emergency liquidity, ease immediate financial pressure, ride out the storm. But financial experts warn this move could sabotage

Pursuing a Doctor of Pharmacy degree represents a significant financial investment. Recent data from the American Association of Colleges of Pharmacy Graduating Student Survey reveals that pharmacy school students typically graduate with debt exceeding $170,000 on average. While federal financial

Think £100 is too small to matter in investing? Most beginners make this mistake. The truth is, starting size matters far less than actually starting. Building real wealth from a modest sum requires understanding which strategies work best for different timelines and risk profiles. Here's what actua

The Reality Check: What Social Security Actually Provides
Millions of Americans depend on Social Security as their primary retirement income stream. According to recent data, approximately 16.4 million people rely exclusively on these monthly benefits. However, the math doesn't quite work out

The automotive landscape is shifting heading into 2026, with several manufacturers expected to adjust their pricing strategies dramatically as market conditions change. For budget-conscious buyers, understanding which vehicles and brands are likely to see substantial price reductions could shape

Financial goal-setting forms the backbone of any sustainable wealth-building strategy. Whether you're an active investor or someone focused on personal finance, understanding the distinction between short-term financial goals and long-term financial goals is essential for proper planning. Both

The collectibles market has always fascinated investors seeking alternative assets, and few categories have experienced the dramatic volatility seen in rare Pokémon cards over the past two decades. What started as trading cards in the pockets of children has transformed into a serious investment

Your loose change drawer might contain nothing special, but certain rare coins—particularly which coins are worth a lot of money among serious collectors—could represent life-changing wealth. Before tossing anything into a change machine, it's worth understanding that some pieces of currency have

DocuSign's third-quarter fiscal 2026 performance presented a paradox that left Wall Street scratching its heads. The company delivered solid earnings results that exceeded forecasts, yet investors responded by punishing the stock, which dropped 4.9% following the December 4 earnings announcement. Th

Background: How Social Security's Retirement Age Has Been Shifting
The Social Security system has undergone a series of automatic adjustments that weren't the result of new legislation, but rather were built into the program decades ago. One particular modification has affected millions of

The FTSE 100 showed minimal movement, closing around 9,838 points amidst mixed economic signals, with improved consumer confidence contrasting with weak retail sales. Select stocks supported the market, while improved government borrowing indicated fiscal stability.

Ryman Healthcare Ltd. reported a significant loss of NZ$49.65 million in the first half of the year, a sharp decline from last year's profit of NZ$58.99 million. Despite revenue growth to NZ$413.78 million, operational challenges impacted profitability. Market response was cautiously optimistic, with shares rising 2.1%.

Arcus Biosciences and Gilead Sciences have terminated the Phase 3 STAR-221 trial due to ineffective results compared to chemotherapy alternatives. Instead, Arcus will focus on developing casdatifan and expanding its pipeline in inflammatory and autoimmune diseases, supported by a strong cash position.

Fighting Back in Search
When ChatGPT first launched, it shook the tech world—suddenly, Google Search faced real competition. But Alphabet didn't stay on the sidelines for long. The company shot back with AI Overviews and AI Mode, turning its search engine into an AI-powered platform. The

Apple is challenging India's new antitrust regulations in court, which allow the Competition Commission to impose penalties based on global revenue, potentially costing Apple $38 billion. The company argues this standard is disproportionate and inequitable, contesting investigations into its market conduct.

Benjamin Graham's value investing framework continues to resonate with modern investors seeking stocks trading below intrinsic value. This analysis examines five healthcare stocks through the lens of Graham's proven methodology, which emphasizes low valuation multiples, strong balance sheets, and

Coinbase Global, Inc. (COIN) outperformed the market with a 2.47% gain, but saw a 30-day increase of only 0.44%, lagging behind sector averages. Analysts predict a decline in quarterly earnings but potential annual growth. COIN's valuation reflects investor expectations despite market volatility.

Zoom Communications (ZM) dropped 2.8% recently but gained 5.26% over the past month. Upcoming earnings on November 24, 2025, are expected to show year-over-year growth. ZM trades at a discount compared to its sector, reflecting cautious analyst sentiment.